Skip to Main content Skip to Navigation
Journal articles

A point mutation in the Ncr1 signal peptide impairs the development of innate lymphoid cell subsets.

Francisca F. Almeida 1 Sara Tognarelli 2 Antoine Marcais 3 Andrew J. Kueh 1 Miriam E. Friede 2 Yang Liao 1 Simon N. Willis 1 Kylie Luong 1 Fabrice Faure 3 Francois E. Mercier 4 Justine Galluso 5 Matthew Firth 1 Emilie Narni-Mancinelli 5 Bushra Rais 2 David T. Scadden 6 Francesco Spallotta 2 Sandra Weil 7 Ariane Giannattasio 7 Franziska Kalensee 2 Tobias Zoller 2 Nicholas D. Huntington 1 Ulrike Schleicher 8 Andreas G. Chiocchetti 2 Sophie Ugolini 5 Marco J. Herold 1 Wei Shi 1 Joachim Koch 7 Alexander Steinle 2 Eric Vivier 5, 9 Thierry Walzer 3 Gabrielle T. Belz 1 Evelyn Ullrich 2
1 WEHI - The Walter and Eliza Hall Institute of Medical Research
2 Goethe-Universität Frankfurt am Main
3 Réponse immunitaire innée dans les maladies infectieuses et auto-immunes – Innate immunity in infectious and autoimmune diseases
CIRI - Centre International de Recherche en Infectiologie - UMR
4 Department of Medecine [Montréal]
5 CIML - Centre d'Immunologie de Marseille - Luminy
6 HSCI - Harvard Stem Cell Institute [Cambridge, USA]
7 Georg-Speyer-Haus
8 FAU - Friedrich-Alexander Universität Erlangen-Nürnberg
9 Innate Pharma
Abstract : NKp46 (CD335) is a surface receptor shared by both human and mouse natural killer (NK) cells and innate lymphoid cells (ILCs) that transduces activating signals necessary to eliminate virus-infected cells and tumors. Here, we describe a spontaneous point mutation of cysteine to arginine (C14R) in the signal peptide of the NKp46 protein in congenic Ly5.1 mice and the newly generated NCR(B6C14R) strain. Ly5.1(C14R) NK cells expressed similar levels of Ncr1 mRNA as C57BL/6, but showed impaired surface NKp46 and reduced ability to control melanoma tumors in vivo. Expression of the mutant NKp46(C14R) in 293T cells showed that NKp46 protein trafficking to the cell surface was compromised. Although Ly5.1(C14R) mice had normal number of NK cells, they showed an increased number of early maturation stage NK cells. CD49a(+)ILC1s were also increased but these cells lacked the expression of TRAIL. ILC3s that expressed NKp46 were not detectable and were not apparent when examined by T-bet expression. Thus, the C14R mutation reveals that NKp46 is important for NK cell and ILC differentiation, maturation and function. Significance Innate lymphoid cells (ILCs) play important roles in immune protection. Various subsets of ILCs express the activating receptor NKp46 which is capable of recognizing pathogen derived and tumor ligands and is necessary for immune protection. Here, we describe a spontaneous point mutation in the signal peptide of the NKp46 protein in congenic Ly5.1 mice which are widely used for tracking cells in vivo. This Ncr1 C14R mutation impairs NKp46 surface expression resulting in destabilization of Ncr1 and accumulation of NKp46 in the endoplasmic reticulum. Loss of stable NKp46 expression impaired the maturation of NKp46(+) ILCs and altered the expression of TRAIL and T-bet in ILC1 and ILC3, respectively.
Keywords : intracellular trafficking activation receptors congenic mice innate lymphoid cells
Document type :
Journal articles
Complete list of metadata

Cited literature [56 references]  Display  Hide  Download
https://hal-amu.archives-ouvertes.fr/hal-02086847
Contributor : Administrateur Hal Amu <>
Submitted on : Monday, April 1, 2019 - 4:08:42 PM
Last modification on : Friday, July 16, 2021 - 3:42:05 AM
Long-term archiving on: : Tuesday, July 2, 2019 - 5:53:04 PM

File

Vignette du document
A point mutation in the Ncr1 s...
Publication funded by an institution

Licence

Distributed under a Creative Commons Attribution - NonCommercial - NoDerivatives 4.0 International License

Identifiers

Collections

UNIV-AMU | CNRS | CERCLE | ENS-LYON | UNIV-LYON1 | CIRI | UDL | CIRI-T-WALZER-LYACTS

Citation

Francisca F. Almeida, Sara Tognarelli, Antoine Marcais, Andrew J. Kueh, Miriam E. Friede, et al.. A point mutation in the Ncr1 signal peptide impairs the development of innate lymphoid cell subsets.. OncoImmunology, Taylor & Francis, 2018, 7 (10), pp.e1475875. ⟨10.1080/2162402X.2018.1475875⟩. ⟨hal-02086847⟩

Export

BibTeX TEI DC DCterms EndNote

Share

Metrics

Record views

759

Files downloads

400